Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_assertion type Assertion NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_head.
- NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_assertion description "[In this study, we carried out a three-stage study in 9529 patients with GD and 9984 controls to identify new risk loci for GD and found genome-wide significant associations in the overall populations for five novel susceptibility loci: the GPR174-ITM2A at Xq21.1, C1QTNF6-RAC2 at 22q12.3-13.1, SLAMF6 at 1q23.2, ABO at 9q34.2 and an intergenic region harboring two non-coding RNAs at 14q32.2 and one previous indefinite locus, TG at 8q24.22 (Pcombined < 5 � 10(-8)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_provenance.
- NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_assertion evidence source_evidence_literature NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_provenance.
- NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_assertion SIO_000772 23612905 NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_provenance.
- NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_assertion wasDerivedFrom befree-20150227 NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_provenance.
- NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_assertion wasGeneratedBy ECO_0000203 NP219885.RAYFfNHDrVzwEn9-LLTWut0_u6DJ93rF5ZeyLR_MrsEe8130_provenance.